Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Terminated 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 2

Conditions

Astrocytoma 8Glioblastoma 5Recurrence 3Oligodendroglioma 2Neuroectodermal Tumors, Primitive 2Neurocytoma 2Glioma 2Brain Neoplasms 2Optic Nerve Glioma 1Neurofibroma 1Neuroblastoma 1Neurilemmoma 1Meningioma 1Gliosarcoma 1Ganglioglioma 1Diffuse Intrinsic Pontine Glioma 1Craniopharyngioma 1Central Nervous System Neoplasms 1

Interventions

Temozolomide 159Bevacizumab 69Radiotherapy 68Magnetic Resonance Spectroscopy 68Irinotecan 31Surgical Procedures, Operative 27Radiation 24Carboplatin 23Specimen Handling 20Carmustine 20Blood Specimen Collection 20Nivolumab 19Aminolevulinic Acid 18Biopsy 17Lomustine 16pembrolizumab 13Radiotherapy, Intensity-Modulated 13Cyclophosphamide 13trametinib 12fluorodopa F 18 12X-Rays 12Radiosurgery 12Erlotinib Hydrochloride 12Topotecan 11Everolimus 11Magnetic Resonance Imaging 10IL13-PE38 10dabrafenib 9Etoposide 9Drug Therapy 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Glioma × antineoplaston AS 2-1 × CNS × Clear all
NCT00003535 2018-03-21

Antineoplaston Therapy in Treating Children With Recurrent or Refractory High-Grade Glioma

Burzynski Research Institute

Phase 2 Terminated
9 enrolled 6 charts
CNS

Astrocytoma, Glioma

NCT00003457 2017-08-22

Antineoplaston Therapy in Treating Patients With Brain Tumors

Burzynski Research Institute

Phase 2 Completed
40 enrolled 6 charts
CNS

Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma, Neuroectodermal Tumors, Primitive, Neurocytoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡